# Lantheus Holdings, Inc. – Consensus ‘buy’ rating and 29.0% Upside Potential

- Link: https://www.directorstalkinterviews.com/lantheus-holdings-inc.consensus-buy-rating-and-29.0-upside-potential/4121175025
- Published: 2024-10-23T15:01:30+01:00
- Author: Charlotte Edwards

**Lantheus Holdings, Inc.** which can be found using ticker (LNTH) now have 11 confirmed
analysts covering the stock with the consensus suggesting a rating of ‘buy’. The
range between the high target price and low target price is between $175.00 and 
$125.00 and has a mean target at $144.55. Now with the previous closing price of
$112.08 and the analysts are correct then we can expect a percentage increase in
value of 29.0%. The day 50 moving average is $106.23 while the 200 day moving average
is $81.83. The company has a market capitalization of 7.82B. Currently the stock
stands at: $112.63 USD

 The potential market cap would be $10,085,442,973 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 18.56, revenue per share of $20.91
and a 17.41% return on assets.

Lantheus Holdings, Inc. is an integrated provider of imaging diagnostics, targeted
therapeutics, and artificial intelligence solutions to find, fight and follow serious
medical conditions. The Company’s products include precision diagnostics, radiopharmaceutical
oncology, and strategic partnerships. Its precision diagnostic products assist healthcare
professionals (HCPs) Find and Follow diseases, with a focus on cardiology. Its radiopharmaceutical
oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Its
strategic partnerships focus on enabling precision medicine through the use of biomarkers,
digital solutions and pharma services platforms, and also includes the Company’s
license of RELISTOR to Bausch Health Companies, Inc. (Bausch). Its commercial products
are used by oncologists, urologists, nuclear medicine physicians, cardiologists,
sonographers, technologists, radiologists, and internal medicine physicians working
in a variety of clinical settings.

Share on: